These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15956073

  • 1. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [Abstract] [Full Text] [Related]

  • 2. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.
    Bernstein CN, Bector S, Leslie WD.
    Am J Gastroenterol; 2003 Nov; 98(11):2468-73. PubMed ID: 14638350
    [Abstract] [Full Text] [Related]

  • 3. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease.
    Benchimol EI, Ward LM, Gallagher JC, Rauch F, Barrowman N, Warren J, Beedle S, Mack DR.
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):538-45. PubMed ID: 18030230
    [Abstract] [Full Text] [Related]

  • 4. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
    Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.
    Am J Kidney Dis; 2003 Jun; 41(6):1163-9. PubMed ID: 12776267
    [Abstract] [Full Text] [Related]

  • 5. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.
    Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK.
    J Cyst Fibros; 2004 Dec; 3(4):233-6. PubMed ID: 15698940
    [Abstract] [Full Text] [Related]

  • 6. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A, Carderi I, Ferrara F, Rizzotto ER, Luisetto G, Camozzi V, Baldo V.
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [Abstract] [Full Text] [Related]

  • 7. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P, Freeman C, Bernstein ML, Lawrence S, Rodd C.
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [Abstract] [Full Text] [Related]

  • 8. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P, Chemlal K, Khalifa P, Wechsler B, De Gennes C, Belmatoug N, Cohen P, Ziza JM, Verdoncq B, Piette JC.
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study.
    Doetsch AM, Faber J, Lynnerup N, Wätjen I, Bliddal H, Danneskiold-Samsøe B.
    Calcif Tissue Int; 2004 Sep; 75(3):183-8. PubMed ID: 15386160
    [Abstract] [Full Text] [Related]

  • 14. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Przegl Lek; 2007 Sep; 64(9):552-8. PubMed ID: 18510075
    [Abstract] [Full Text] [Related]

  • 15. The role of the therapeutic team in shaping eating habits and lifestyle in children with dietary calcium deficiency.
    Górska A, Konstantynowicz J, Chlabicz S, Urban M, Kaczmarski M.
    Rocz Akad Med Bialymst; 2005 Sep; 50 Suppl 1():119-22. PubMed ID: 16119643
    [Abstract] [Full Text] [Related]

  • 16. Positive association between the course of vitamin D intake and bone mineral density at 36 years in men.
    van Dijk CE, de Boer MR, Koppes LL, Roos JC, Lips P, Twisk JW.
    Bone; 2009 Mar; 44(3):437-41. PubMed ID: 19061980
    [Abstract] [Full Text] [Related]

  • 17. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z, Cetinkaya E, Darendeliler F, Vidinlisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Bundak R.
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [Abstract] [Full Text] [Related]

  • 18. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 May; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 19. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM, Elstein D, Hrebícek M, Zimran A.
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [Abstract] [Full Text] [Related]

  • 20. Bone mineral density in children with celiac disease. Effect of a Gluten-free diet.
    Tau C, Mautalen C, De Rosa S, Roca A, Valenzuela X.
    Eur J Clin Nutr; 2006 Mar; 60(3):358-63. PubMed ID: 16319837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.